Trump Issues 60-Day Deadline for Drug Makers to Lower Prices

In letters to 17 pharmaceutical companies, the president called for swift action to implement most-favored-nation prescription drug pricing.

Logo of global biopharmaceutical company Bristol-Myers Squibb on its building in Le Passage, near Agen, France, on March 29, 2018. Regis Duvignau/Reuters

President Donald Trump has told CEOs of the world’s leading pharmaceutical companies that he expects them to implement Most Favored Nation drug pricing within 60 days.

The president sent letters to 17 drug makers, including several headquartered overseas, announcing that he would “deploy every tool” available “to protect American families from continued abusive drug pricing practices.”